ARMO Overview
Upcoming Projects (ARMO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (ARMO)
-
Discussing non-small cell lung cancer (NSCLC) and the role cytokines can play in the disease, with a focus on AM0010 and NKTR-214
Tickers: ARMO, NKTR
Executed On: May 10, 2018 at 04:00 PM EDT -
Discussing the NSCLC landscape after KEYNOTE-189 data, specifically PD-1 combo programs
Tickers: MRK, ARMO, NKTR
Executed On: Apr 30, 2018 at 10:00 AM EDT
Upcoming & Overdue Catalysts (ARMO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (ARMO)
-
Phase 2 pegilodecakin (PEG-rhuIL-10) in combination with PD-1 antibody (pembrolizumab or nivolumab) in second-line NSCLC
Ticker: ARMO
Occurred on: Jun 02, 2018
Strategic Initiatives (ARMO)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
